Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

Conditions

• Hormonal Gender-Affirming Therapy

Eligibility Criteria

Sex

ALL

Age

14 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Spirometry — DIAGNOSTIC_TEST
  Pulmonary function test to measure lung function
• Plethysmography — DIAGNOSTIC_TEST
  Pulmonary function test to measure lung volume

Study Details

The purpose of this research study is to evaluate whether undergoing gender affirming care will impact the way the lungs function.

Key Dates

Start date

Feb 1, 2023

Status verified

May 2026

Primary completion

Jul 31, 2027

Completion

Jul 31, 2027

Study Design

Enrollment

44 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Arms

• Experimental: Pulmonary Function in Transgender and Gender Diverse Patients
  Transgender and gender diverse (TGD) patients undergoing masculinizing or feminizing hormone therapies will have breathing tests to evaluate their lung function

Primary Outcome Measure

Change in lung volume (Total Lung Capacity, Vital Capacity, Functional Residual Capacity, Residual Volume) [ Time Frame: Baseline, 6-month Follow-Up, 12-month Follow-Up, 18-month Follow-Up ]

Central Contacts

• Kayla Quinn, MS
  800-752-1606
  [email protected]

Locations (1)

Find similar trials in Rochester, MN